Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Fallopian Tube Neoplasms 3Ovarian Neoplasms 2Carcinoma, Ovarian Epithelial 2Uterine Cervical Neoplasms 1Neoplasms 1Melanoma 1Carcinoma, Hepatocellular 1Breast Neoplasms, Male 1Breast Neoplasms 1Anxiety Disorders 1

Interventions

Cognitive Behavioral Therapy 2Behavior Therapy 2Uncertainty 1Therapeutics 1Surveys and Questionnaires 1Psychosocial Intervention 1Psychiatric Rehabilitation 1Propranolol 1Methods 1Hepatitis B Vaccines 1Early Intervention, Educational 1Dehydroepiandrosterone 1Counseling 1Cognitive Restructuring 1Acceptance and Commitment Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anxiety Disorders × Propranolol × Gynecologic × Clear all
NCT01902966 2021-10-12

Feasibility - Beta Adrenergic Blockade (BB) in Cervical Cancer (CX)

M.D. Anderson Cancer Center

Phase NA Terminated
6 enrolled 8 charts
Gynecologic

Anxiety Disorders, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡